About Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency is a rare disease catalogued by Orphanet (ORPHA:1900). It is associated with the PLOD1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency trials.
Search ClinicalTrials.gov for "Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency" or filter by Orphanet code ORPHA:1900 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency. Updated daily.